Picture of Biotest AG logo

BIO Biotest AG Income Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeMid CapSucker Stock

Annual income statement for Biotest AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue400419484516516
Cost of Revenue
Gross Profit13512913080.7125
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses390420486563533
Operating Profit10.6-1.2-1.3-47.1-16.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-6-1.3-30-62.6-30.8
Provision for Income Taxes
Net Income After Taxes-12.9-4.7-31.4-63.3-31.6
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income182-4.7-31.4-63.3-31.6
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income181-4.81-32.2-65-32.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.3-0.076-0.83-3.39-1.64
Dividends per Share